InvestorsHub Logo
Followers 0
Posts 4010
Boards Moderated 0
Alias Born 07/26/2006

Re: None

Thursday, 05/19/2011 11:19:38 AM

Thursday, May 19, 2011 11:19:38 AM

Post# of 320
Canaccord analyst says, "Following a recent positive vote by an FDA panel, we see and are in line with high Street expectations for DIFICID approval for treatment ...

http://www.streetinsider.com/Analyst+Comments/Canaccord+Genuity+Reiterates+a+Buy+on+Optimer+Pharmaceuticals+(OPTR)%3B+Model+Revisions+Ahead+of+DIFICID+Launch/6522161.html